Pharmacokinetic study of rolapitant + midazolam in volunteers.

Trial Profile

Pharmacokinetic study of rolapitant + midazolam in volunteers.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Jul 2013

At a glance

  • Drugs Rolapitant (Primary) ; Midazolam
  • Indications Anxiety disorders; Chemotherapy-induced nausea and vomiting
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 Jul 2013 New trial record
    • 28 Jun 2013 Results presented at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) International Symposium, according to a TESARO media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top